DSLT to reduce glaucoma eye drops
Part of Eyes & vision clinical trials.
This trial is testing a laser treatment called DSLT to see if it can help people with glaucoma use fewer eye drops. It may be a good option if your eye pressure is already controlled with medication and you haven't had glaucoma surgery before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be an adult.
- You have ocular hypertension or primary open-angle glaucoma.
- Your eye pressure is controlled (21 mmHg or below) with 1 to 3 different eye drops.
- You have not had any glaucoma surgery before (like trabeculectomy, laser, or stents).
- You have not had cataract surgery in the last 2 years.
- You do not have other serious eye conditions (like advanced cataracts or retinal disease) that could interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new laser treatment called DSLT for people who have just been diagnosed with open-angle glaucoma or a similar condition like ocular hypertension. It aims to see if the laser can lower eye pressure by at least 20% after six months without needing any eye drops.
This study is for people who already joined an earlier selective laser eye treatment trial and were able to be followed without needing stronger additional treatments. It looks at the best plan for repeating the laser treatment when appropriate.
This trial tests a laser treatment called DSLT to see how it affects eye pressure changes over 6 months. It may help people with open-angle glaucoma or high eye pressure who are currently using 0 to 3 types of pressure-lowering eye drops.
This trial tests a laser treatment called DSLT in people recently diagnosed with open-angle glaucoma who have never had any other glaucoma treatment. It aims to see how well the laser lowers eye pressure.
This study tests a newer type of laser treatment for glaucoma, called direct selective laser trabeculoplasty (DSLT), in people who have already had a standard SLT laser before. It aims to see if DSLT can further lower eye pressure, which may help protect your vision.
This trial tests a laser procedure called DSLT to lower eye pressure in people with pigmentary glaucoma. It may offer a treatment option for those who have not had prior glaucoma surgeries.
Hear when a new Primary Open Angle Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.